Click to search for your profile
Click to search for condition or expert
Click to open main menu
Malignant Mixed Mullerian Tumor Clinical Trials
Find Malignant Mixed Mullerian Tumor Clinical Trials Near You
Find a Doctor
Match to trials
Find the right clinical trials for you in under a minute
Customize your search results with filters
You can select from the dropdown list OR enter your own terms to refine the search.
Need to find the closest trial?
Sort By Distance
Save trials for later
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances
Newest Clinical Trials
1 Active Filter
Found 1 clinical trials
An Open-Label, Multicenter, Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel to Assess Safety, Tolerability, and Pharmacokinetics in Patients With Advanced or Metastatic Solid Tumors
Who is this study for:
Patients with Solid Tumor
September 19, 2018
Phase 1/Phase 2
This is an open-label Phase 1b/2 multicenter study of rebastinib (DCC-2036) in combination with paclitaxel designed to evaluate the safety, tolerability, and pharmacokinetics (PK) in patients with advanced or metastatic solid tumors.
Showing 1-1 of 1